Cervical Sympathetic Blockade for Psychogenic Nonepileptic Seizures Associated With Post-traumatic Stress Disorder: A Case Report and Neurobiological Framework

Study Overview

The investigation centers around the application of cervical sympathetic blockade in managing psychogenic nonepileptic seizures (PNES) in a patient diagnosed with post-traumatic stress disorder (PTSD). This case report highlights an innovative approach to treatment, showing how targeting the sympathetic nervous system may alleviate the severity and frequency of PNES episodes. The interplay between PTSD and PNES is complex; trauma can manifest not only as psychological symptoms but also as seizures that do not have a neurological basis, complicating the clinical picture.

The subject of the study is a female patient with a history of severe trauma, leading to a diagnosis of PTSD and subsequent episodes of PNES. Through this lens, the report aims to bridge the gap between psychological and physiological responses to trauma, presenting a neurobiological framework that underlines the significant role of the autonomic nervous system in mental health disorders. By utilizing cervical sympathetic blockade, the study seeks to disrupt the pathological patterns linked to stress responses that may trigger or exacerbate PNES.

The overarching aim is to illustrate how addressing the neurocircuitry involved in PTSD can lead to a better understanding of PNES, ultimately guiding more effective treatment strategies. This case not only contributes to existing literature but also serves as a foundation for future research into the relationship between sympathetic nervous system activity and psychogenic disorders, emphasizing the necessity for a multidisciplinary approach to treatment.

Methodology

This case report employed a detailed and systematic approach to assess the effectiveness of cervical sympathetic blockade in a patient with PTSD and PNES. The patient, a 35-year-old woman with a documented history of severe psychological trauma, was evaluated through a combination of clinical assessments, neurobiological evaluations, and therapeutic interventions.

The assessment process began with comprehensive clinical interviews to gather the patient’s medical history, symptomatology, and previous therapeutic attempts. A standardized assessment scale for PTSD, such as the Clinician-Administered PTSD Scale (CAPS), was utilized to quantify the severity of her symptoms and to monitor changes throughout treatment. Additionally, the frequency and intensity of PNES episodes were meticulously recorded in a seizure diary by the patient, allowing for accurate tracking of her condition’s progression.

Prior to the intervention, the patient underwent a thorough medical examination, including cardiac assessments, to rule out any contraindications to the cervical sympathetic blockade procedure. Neuroimaging studies, such as MRI or CT scans, were also performed to ensure there were no underlying neurological causes for the seizures. This comprehensive evaluation helped ensure that the treatment could be safely implemented.

Once deemed suitable for the procedure, cervical sympathetic blockade was performed under fluoroscopic guidance to ensure precision. The injection involved a local anesthetic and corticosteroid targeting the sympathetic chain around the cervical spine. This method aimed to temporarily interrupt sympathetic nerve pathways, which are believed to be overactive in individuals experiencing PNES. The procedure was conducted in a controlled clinic setting, adhering to established guidelines for interventional pain management.

Post-treatment, the patient was monitored for immediate side effects and evaluated for changes in both PTSD and PNES symptoms using the same scales employed in the initial assessment. Follow-up appointments were scheduled to assess the durability of the intervention effects over time, with particular attention to any changes in seizure frequency, intensity, and overall functionality in daily life activities.

Throughout the study, the patient’s subjective experience of trauma symptoms was also prioritized, with qualitative feedback collected through regular discussions during follow-up visits. This dual approach—combining quantitative assessments with qualitative experiences—aimed to provide a holistic view of the treatment’s impact on the patient’s well-being.

The methodology was designed to ensure rigor and reproducibility, allowing for the eventual publication of findings that could guide further research and clinical practice in the treatment of PNES associated with PTSD. The multi-faceted approach to evaluating the efficacy of cervical sympathetic blockade not only focused on the physiological outcomes but also considered the intricate relationship between the patient’s mental and emotional health in response to the intervention.

Key Findings

The application of cervical sympathetic blockade has demonstrated promising results in the treatment of psychogenic nonepileptic seizures (PNES) among patients diagnosed with post-traumatic stress disorder (PTSD). In the case of the patient under observation, significant reductions in both the frequency and intensity of PNES episodes were noted following the intervention. Over a follow-up period of several months, the patient reported a marked decrease in the number of seizures, with a documented reduction of over 70% in seizure occurrences as logged in her seizure diary. This improvement coincided with a tangible reduction in the severity of PTSD symptoms, as measured by the Clinician-Administered PTSD Scale (CAPS).

Additionally, the patient expressed qualitative improvements in her mental state, reporting enhanced overall daily functionality and a better quality of life. The relief gained from the blockade intervention appeared to facilitate greater engagement in therapeutic activities and daily living, which had previously been severely hampered by the frequency of her seizures and trauma-related symptoms. Clinical assessments indicated that the reduction in sympathetic nervous system hyperactivity may have played a crucial role in alleviating the psychological burden associated with PTSD, showcasing a potential neurobiological link between the two conditions.

No significant adverse effects from the cervical sympathetic blockade procedure were reported, underscoring its safety as a treatment option for patients with PTSD and PNES. The multidisciplinary approach to treatment, which included ongoing psychological support, ensured that the patient’s emotional and psychological needs were addressed alongside physiological interventions.

Furthermore, neuroimaging analyses conducted before and after the intervention revealed no structural abnormalities that could account for her seizures, reinforcing the understanding that PNES in this case were rooted in psychological trauma rather than direct neurological dysfunction. This finding bolsters the argument for considering alternative interventions targeting the autonomic nervous system, as traditional anti-epileptic medications were ineffective for her condition.

The findings from this case report not only highlight the efficacy of cervical sympathetic blockade in managing PNES associated with PTSD, but also encourage further exploration into the interplay between the sympathetic nervous system and trauma-related disorders. In doing so, it opens doors for future research aimed at optimizing treatment approaches for patients grappling with the dual challenges of psychological trauma and seizure disorders.

Clinical Implications

The findings from this study carry several important clinical implications for the management of patients suffering from psychogenic nonepileptic seizures (PNES) associated with post-traumatic stress disorder (PTSD). Given the observed efficacy of cervical sympathetic blockade, clinicians may consider this procedure as a viable treatment option, particularly for individuals whose symptoms have not improved with conventional therapies. The dramatic reduction in seizure frequency and the associated alleviation of PTSD symptoms highlight the potential benefits of targeting the sympathetic nervous system as part of a comprehensive treatment strategy.

Moreover, this case emphasizes the necessity for a multidisciplinary approach to manage such complex conditions. Collaboration between neurologists, psychiatrists, and pain management specialists can create a more holistic treatment plan that addresses both the psychological and physiological aspects of PNES. Such an integrated model can enhance therapeutic outcomes, as it allows for the incorporation of various treatment modalities, including psychotherapy, pharmacotherapy, and interventions like cervical sympathetic blockade.

Additionally, the qualitative improvements reported by the patient suggest that successful management of PNES can lead to significant enhancements in the overall quality of life. As the relief from symptoms allows patients to engage more fully in daily activities and therapies, healthcare providers should remain attentive to both the functional improvements and the emotional well-being of these individuals. This aspect is particularly crucial, as traditional medical assessments often focus on objective measures of seizure frequency rather than the broader impacts on the patient’s functionality and mental health.

It’s also worth noting that this study contributes to a growing body of evidence supporting the theory that psychological trauma can elicit physiological responses that manifest as seizure-like episodes. The insights gained from this case may inspire further research into the neurobiological mechanisms linking PTSD and PNES. Such studies could potentially lead to even more refined treatment options that could better serve patients who experience psychological trauma in conjunction with seizure disorders.

Safety concerns are paramount in the adoption of new procedures in clinical practice. The absence of significant adverse effects reported in this case supports the safety profile of cervical sympathetic blockade. However, further research involving larger patient populations is necessary to confirm these findings and to understand the long-term effects of this intervention comprehensively. This exploration would ensure that best practices are developed and that clinicians can confidently recommend this treatment to their patients without compromising safety.

The implications of this case report extend beyond individual treatment protocols. They encourage a re-evaluation of how PNES and PTSD are understood and managed in clinical settings. By acknowledging the intersection of the psychological and physiological realms, practitioners can better address the needs of patients suffering from the debilitating effects of trauma-related seizure disorders.

Scroll to Top